227 related articles for article (PubMed ID: 10869238)
1. A new locus on chromosome 12p13.3 for pseudohypoaldosteronism type II, an autosomal dominant form of hypertension.
Disse-Nicodème S; Achard JM; Desitter I; Houot AM; Fournier A; Corvol P; Jeunemaitre X
Am J Hum Genet; 2000 Aug; 67(2):302-10. PubMed ID: 10869238
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic and genetic heterogeneity of familial hyperkalaemic hypertension (Gordon syndrome).
Achard JM; Disse-Nicodeme S; Fiquet-Kempf B; Jeunemaitre X
Clin Exp Pharmacol Physiol; 2001 Dec; 28(12):1048-52. PubMed ID: 11903313
[TBL] [Abstract][Full Text] [Related]
3. Genetic heterogeneity of familial hyperkalaemic hypertension.
Disse-Nicodeme S; Desitter I; Fiquet-Kempf B; Houot AM; Stern N; Delahousse M; Potier J; Ader JL; Jeunemaitre X
J Hypertens; 2001 Nov; 19(11):1957-64. PubMed ID: 11677360
[TBL] [Abstract][Full Text] [Related]
4. Multilocus linkage of familial hyperkalaemia and hypertension, pseudohypoaldosteronism type II, to chromosomes 1q31-42 and 17p11-q21.
Mansfield TA; Simon DB; Farfel Z; Bia M; Tucci JR; Lebel M; Gutkin M; Vialettes B; Christofilis MA; Kauppinen-Makelin R; Mayan H; Risch N; Lifton RP
Nat Genet; 1997 Jun; 16(2):202-5. PubMed ID: 9171836
[TBL] [Abstract][Full Text] [Related]
5. A locus for autosomal dominant hereditary spastic ataxia, SAX1, maps to chromosome 12p13.
Meijer IA; Hand CK; Grewal KK; Stefanelli MG; Ives EJ; Rouleau GA
Am J Hum Genet; 2002 Mar; 70(3):763-9. PubMed ID: 11774073
[TBL] [Abstract][Full Text] [Related]
6. A mouse model of pseudohypoaldosteronism type II reveals a novel mechanism of renal tubular acidosis.
López-Cayuqueo KI; Chavez-Canales M; Pillot A; Houillier P; Jayat M; Baraka-Vidot J; Trepiccione F; Baudrie V; Büsst C; Soukaseum C; Kumai Y; Jeunemaître X; Hadchouel J; Eladari D; Chambrey R
Kidney Int; 2018 Sep; 94(3):514-523. PubMed ID: 30146013
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of pseudohypoaldosteronism type 2 by WNK1 mutations.
Bergaya S; Vidal-Petiot E; Jeunemaitre X; Hadchouel J
Curr Opin Nephrol Hypertens; 2012 Jan; 21(1):39-45. PubMed ID: 22080857
[TBL] [Abstract][Full Text] [Related]
8. Pseudohypoaldosteronism Type II: A Young Girl Presented with Hypertension, Hyperkalemia and Metabolic Acidosis.
Sethar GH; Almoghawi A; Khan N; Altourah W; Ashour NM
J Coll Physicians Surg Pak; 2018 Mar; 28(3):S21-S22. PubMed ID: 29482694
[TBL] [Abstract][Full Text] [Related]
9. Localisation of pseudohypoaldosteronism genes to chromosome 16p12.2-13.11 and 12p13.1-pter by homozygosity mapping.
Strautnieks SS; Thompson RJ; Hanukoglu A; Dillon MJ; Hanukoglu I; Kuhnle U; Seckl J; Gardiner RM; Chung E
Hum Mol Genet; 1996 Feb; 5(2):293-9. PubMed ID: 8824886
[TBL] [Abstract][Full Text] [Related]
10. A locus for brachydactyly type A-1 maps to chromosome 2q35-q36.
Yang X; She C; Guo J; Yu AC; Lu Y; Shi X; Feng G; He L
Am J Hum Genet; 2000 Mar; 66(3):892-903. PubMed ID: 10712204
[TBL] [Abstract][Full Text] [Related]
11. Linkage of Gitelman syndrome to the thiazide-sensitive sodium-chloride cotransporter gene with identification of mutations in Dutch families.
Lemmink HH; van den Heuvel LP; van Dijk HA; Merkx GF; Smilde TJ; Taschner PE; Monnens LA; Hebert SC; Knoers NV
Pediatr Nephrol; 1996 Aug; 10(4):403-7. PubMed ID: 8865231
[TBL] [Abstract][Full Text] [Related]
12. Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities.
Boyden LM; Choi M; Choate KA; Nelson-Williams CJ; Farhi A; Toka HR; Tikhonova IR; Bjornson R; Mane SM; Colussi G; Lebel M; Gordon RD; Semmekrot BA; Poujol A; Välimäki MJ; De Ferrari ME; Sanjad SA; Gutkin M; Karet FE; Tucci JR; Stockigt JR; Keppler-Noreuil KM; Porter CC; Anand SK; Whiteford ML; Davis ID; Dewar SB; Bettinelli A; Fadrowski JJ; Belsha CW; Hunley TE; Nelson RD; Trachtman H; Cole TR; Pinsk M; Bockenhauer D; Shenoy M; Vaidyanathan P; Foreman JW; Rasoulpour M; Thameem F; Al-Shahrouri HZ; Radhakrishnan J; Gharavi AG; Goilav B; Lifton RP
Nature; 2012 Jan; 482(7383):98-102. PubMed ID: 22266938
[TBL] [Abstract][Full Text] [Related]
13. Gitelman's syndrome (Bartter's variant) maps to the thiazide-sensitive cotransporter gene locus on chromosome 16q13 in a large kindred.
Pollak MR; Delaney VB; Graham RM; Hebert SC
J Am Soc Nephrol; 1996 Oct; 7(10):2244-8. PubMed ID: 8915985
[TBL] [Abstract][Full Text] [Related]
14. A new locus for autosomal dominant "pure" hereditary spastic paraplegia mapping to chromosome 12q13, and evidence for further genetic heterogeneity.
Reid E; Dearlove AM; Rhodes M; Rubinsztein DC
Am J Hum Genet; 1999 Sep; 65(3):757-63. PubMed ID: 10441583
[TBL] [Abstract][Full Text] [Related]
15. A novel locus for autosomal dominant nonsyndromic hearing loss identified at 5q31.1-32 in a Chinese pedigree.
Xia J; Deng H; Feng Y; Zhang H; Pan Q; Dai H; Long Z; Tang B; Deng H; Chen Y; Zhang R; Zheng D; He Y; Xia K
J Hum Genet; 2002; 47(12):635-40. PubMed ID: 12522684
[TBL] [Abstract][Full Text] [Related]
16. Pseudohypoaldosteronism type II: marked sensitivity to thiazides, hypercalciuria, normomagnesemia, and low bone mineral density.
Mayan H; Vered I; Mouallem M; Tzadok-Witkon M; Pauzner R; Farfel Z
J Clin Endocrinol Metab; 2002 Jul; 87(7):3248-54. PubMed ID: 12107233
[TBL] [Abstract][Full Text] [Related]
17. Further evidence for genetic heterogeneity within type II autosomal dominant osteopetrosis.
Bénichou OD; Bénichou B; Copin H; De Vernejoul MC; Van Hul W
J Bone Miner Res; 2000 Oct; 15(10):1900-4. PubMed ID: 11028441
[TBL] [Abstract][Full Text] [Related]
18. Familial Hyperkalemia and Hypertension (FHHt) and KLHL3: Description of a Family with a New Recessive Mutation (S553L) Compared to a Family with a Dominant Mutation, Q309R, with Analysis of Urinary Sodium Chloride Cotransporter.
Kliuk-Ben Bassat O; Carmon V; Hanukoglu A; Ganon L; Massalha E; Holtzman EJ; Farfel Z; Mayan H
Nephron; 2017; 137(1):77-84. PubMed ID: 28511177
[TBL] [Abstract][Full Text] [Related]
19. A locus for an autosomal dominant form of progressive renal failure and hypertension at chromosome 1q21.
Cohn DH; Shohat T; Yahav M; Ilan T; Rechavi G; King L; Shohat M
Am J Hum Genet; 2000 Sep; 67(3):647-51. PubMed ID: 10930359
[TBL] [Abstract][Full Text] [Related]
20. Dominant intermediate Charcot-Marie-Tooth neuropathy maps to chromosome 19p12-p13.2.
Kennerson ML; Zhu D; Gardner RJ; Storey E; Merory J; Robertson SP; Nicholson GA
Am J Hum Genet; 2001 Oct; 69(4):883-8. PubMed ID: 11533912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
